Related Experiment Video

Updated: Sep 28, 2026

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

Carotid artery intimal-medial thickness: indicator of atherosclerotic burden and response to risk factor modification

Debabrata Mukherjee1, Jay S Yadav

  • 1Division of Cardiology, University of Michigan, Ann Arbor, Mich, USA.

American Heart Journal
|November 8, 2002
PubMed

Insights

Measuring carotid intimal-medial thickness (CIMT) using ultrasound is a reliable indicator of atherosclerosis severity. Studies show statins, ACE inhibitors, and insulin sensitizers can reduce CIMT and prevent cardiovascular events like heart attack and stroke.

Area of Science:

  • Vascular Medicine
  • Diagnostic Imaging
  • Cardiovascular Disease Research

Background:

  • B-mode ultrasound is utilized to assess carotid intimal-medial thickness (CIMT) as a marker for carotid atherosclerosis severity.
  • Carotid atherosclerosis is a significant risk factor for cardiovascular events.

Purpose of the Study:

  • To review and critique methodologies for measuring CIMT.
  • To evaluate the impact of lifestyle modifications and therapeutic agents on CIMT and cardiovascular outcomes.

Main Methods:

  • Systematic review of high-quality studies focusing on clinical end points.
  • Analysis of data on carotid intimal-medial thickness in relation to atherosclerosis severity.

Main Results:

  • Measurements of CIMT exhibit a high degree of reproducibility across studies.
  • Agents including statins, angiotensin-converting enzyme inhibitors, and insulin sensitizers have been shown to decrease CIMT.
  • These interventions are associated with a reduction in cardiovascular events such as myocardial infarction and stroke.

Conclusions:

  • The review critically examines various CIMT measurement techniques.
  • The efficacy of lifestyle changes and pharmacological treatments in improving CIMT and reducing cardiovascular risk is assessed.
Abstract

More Related Videos

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology09:33

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

Published on: February 7, 2015

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...